Fact CheckerSign in

NCT07384728Not yet recruiting

Ramadan Experience of Individuals With Type 2 Diabetes

The Impact of Ramadan Experiences on Treatment, Psychological and Glycemic Control Levels, and Adherence in Individuals With Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 3 Feb 2026

Brief summary (registry, in English)

This study aims to examine the effects of fasting during Ramadan on treatment adherence, psychological adjustment, and glycemic control in individuals with type 2 diabetes. While Ramadan fasting is a religious practice, it can also pose health risks such as hypoglycemia, hyperglycemia, and metabolic imbalance in individuals with diabetes. Adherence to treatment and self-care, as well as psychosocial adjustment, are crucial in the effective management of diabetes. Given that a large portion of Turkey's population is Muslim, comparing individuals with type 2 diabetes who fast and those who do not during Ramadan will contribute to improving patient care within a cultural and religious context. The findings of this study are expected to guide nurses in developing personalized, culturally sensitive care plans tailored to the needs of individuals before, during, and after Ramadan.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
6 Jan 2026
Start date
3 Jan 2026
Primary completion date
20 Feb 2026
Lead sponsor
Dilan aktepe coşar
NCT number
NCT07384728

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 3 Jan 2026 to the primary completion date, 20 Feb 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of psychiatric illness
  • Presence of cognitive impairment

Lab values

  • Receiving additional treatments that significantly affect glucose levels (e.g., ongoing steroid therapy)

Other

  • Individuals who have decided not to fast during Ramadan
  • Individuals who have stopped fasting during Ramadan

Who the study is looking for

  • Individuals ≥18 years of age
  • Able to give informed consent
  • Diagnosed with type 2 diabetes
  • Planning to fast during Ramadan

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gümüşhane Üniversitesi
Coordinator of this site? Confirm its status
GümüşhaneTurkey (Türkiye)Unknown status
Gümüşhane Universıty
Coordinator of this site? Confirm its status
GümüşhaneTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.